{"favorite_id": 3817, "full_title_en": "Simon Broome Diagnostic Criteria for Familial Hypercholesterolemia (FH)", "short_title_en": "Simon Broome Diagnostic Criteria", "medium_description_en": "Diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.", "short_description_en": "Diagnoses familial hypercholesterolemia (FH).", "specialty_en": ["Endocrinology", "Family Practice", "Internal Medicine"], "system_en": ["Endocrine and Metabolic"], "disease_en": ["Dyslipidemia"], "chief_complaint_en": ["Chest Pain", "Mass"], "purpose_en": ["Diagnosis"], "search_abbreviation_en": ["FH", "HeFH", "gene", "dna", "xanthomas", "high cholesterol", "hypercholesterolemia", "familial"], "seo": {"meta_description_en": "The Simon-Broome Diagnostic Criteria diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.", "keywords_en": "simon-broome, FH diagnosis, Familial hypercholesterolemia diagnosis, fh dx,  familial high cholesterol dx, genetic high cholesterol, HeFH, FH, gene, dna, xanthomas, high cholesterol"}, "content": {"how_to_use": {"use_case_en": "<p>Patients suspected to have familial hypercholesterolemia (FH) by clinical and laboratory features.</p>", "pearls_pitfalls_en": "<ul> <li>The Simon Broome Diagnostic Criteria for FH are the most widely used criteria for diagnosing FH in the UK. </li> <li>Stratifies likelihood into one of three categories: definite, probable, and unlikely.</li> <li>May have limited validity in non-British populations.</li> <li>Requires DNA testing for complete data.</li> </ul>", "why_use_en": "<ul> <li>Patients with FH are at increased risk for coronary heart disease, yet many patients remain undiagnosed.</li> <li>NICE guidelines for FH recommend using the Simon Broome criteria for diagnosis of FH in the UK.</li> <li>Other accepted criteria for diagnosis of FH include the <calculator id=\"3820\">US MEDPED Criteria</calculator> and the <calculator id=\"3818\">Dutch Criteria</calculator>. The risk factors in each criteria set are similar, and clinical judgment as well as local practice factors (similarity of target population to study population) should be considered.</li> </ul>"}, "next_steps": {"advice_en": "<p>Consider lifestyle changes, drug therapy, family testing, and other measures to manage FH if diagnosed.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Selection of appropriate criteria.</p>", "more_info_en": "<p><strong>Simon Broome Diagnosis Criteria for Familial Hypercholesterolemia:</strong></p> <table class=\"table table-bordered table-hover\"> <tbody> <tr> <th>Diagnosis</th> <th>Criteria</th> </tr> <tr> <td rowspan=\"6\">Definite FH</td> <td>Cholesterol &gt;7.5 mmol/L or LDL-cholesterol &gt;4.9 mmol/L in adult</td> </tr> <tr> <td>Cholesterol &gt;6.7 mmol/L or LDL-cholesterol &gt;4.0 mmol/L in a child under 16 years of age</td> </tr> <tr> <td>PLUS</td> </tr> <tr> <td>Tendon xanthomas in patient or a 1st degree relative (parent, sibling, child),<br>or in a 2nd degree relative (grand parent, uncle, aunt)</td> </tr> <tr> <td>OR</td> </tr> <tr> <td>DNA based evidence of a functional LDLR, PCSK9 and APOB mutation</td> </tr> <tr> <td rowspan=\"6\">Probable FH</td> <td>Cholesterol &gt;7.5 mmol/L or LDL-cholesterol &gt;4.9 mmol/L in adult</td> </tr> <tr> <td>Cholesterol &gt;6.7 mmol/L or LDL-cholesterol &gt;4.0 mmol/L in a child under 16 years of age</td> </tr> <tr> <td>PLUS</td> </tr> <tr> <td>Family History of myocardial infarction (MI) before 50 years of age in a 2nd degree relative<br>or below age 60 in a 1st degree relative</td> </tr> <tr> <td>OR</td> </tr> <tr> <td>Family history of raised total cholesterol - &gt;7.5 mmol/L in adult 1st or 2nd degree relative<br>or &gt;6.7 mmol/L in a child or sibling aged &lt;16 years</td> </tr> </tbody> </table>", "evidence_based_medicine_en": "<p>The Simon Broome Register was developed in 1980 in the UK, funded by the widow of a patient named Simon Broome, who died prematurely from coronary heart disease. The diagnostic criteria were developed and validated in a prospective cohort study of 526 patients with confirmed heterozygous FH (<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1671226/\" target=\"_blank\">Simon Broome Register Group 1991</a>).</p> <p>The study\u2019s objective was to examine mortality in patients with FH. Patients were age 20-74 years at the time of registration and had biochemically confirmed heterozygous FH.</p> <p>The investigators found that by using the selected criteria, age-specific cardiac-related mortality in younger FH patients (age 20-39 years) was increased 100-fold compared to the general population, with overall mortality increased 10-fold.</p> <p>Similar findings were reported in a <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/9920511\" target=\"_blank\">subsequent study in 1999</a> by the same group. They also found that initiating lipid-lowering therapy improved cardiac-related mortality, but non-cardiac mortality was not increased at any age (RR for all ages 0.68, 0.45-0.99).</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1671226/", "text": "Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ\u202f: British Medical Journal. 1991;303(6807):893-896."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976735/", "text": "Al-Rasadi K, Al-Waili K, Al-Sabti HA, et al. Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population. Oman Medical Journal. 2014;29(2):85-91. doi:10.5001/omj.2014.22."}, {"href": "https://www.nice.org.uk/guidance/CG71/chapter/1-Guidance#diagnosis", "text": "National Institute for Health and Care Excellence, 2016. Familial hypercholesterolaemia: identification and management. London: NICE."}, {"href": "https://heartuk.org.uk/simon-broome-register-patients-info", "text": "What is the Simon Broome Register? HEART UK. "}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/9920511", "text": "Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis. 1999 Jan;142(1):105-12."}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. John Betteridge", "qa_en": "", "creator_info": {"about_en": "<p>John Betteridge, BSc, MB BS, PhD, MD, FRCP, FAHA, is a practicing endocrinologist at University College London. He is a past chairman of HEART UK and past president of the Council on Lipids in Clinical Medicine at The Royal Society of Medicine. Prof Betteridge is an active researcher with over 300 publications in peer-reviewed journals, with a focus in diabetes and lipid management.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/john-betteridge-md.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Betteridge%20DJ%5BAuthor%5D"}}]}, "instructions_en": "", "input_schema": [{"label_en": "Age (years)", "options": [{"label": "<16", "value": 1}, {"label": "\u226516", "value": 2}], "show_points": false, "type": "toggle", "name": "age", "optional": false}, {"label_en": "Total cholesterol", "unit": "chol_total", "type": "textbox", "name": "tchol", "optional": false, "unit_info": {"name": "Total Cholesterol", "conversion": 0.02586, "error_min": 100, "error_max": 1000, "warn_min": 150, "warn_max": 500, "normal_max_si": 5.2, "normal_min_si": 3.9, "normal_min_us": 150, "units_si": "mmol/L", "units_us": "mg/dL", "normal_max_us": 200}}, {"label_en": "LDL cholesterol", "unit": "chol_ldl", "type": "textbox", "name": "ldl", "optional": false, "unit_info": {"name": "LDL Cholesterol", "conversion": 0.0259, "error_min": 40, "error_max": 700, "warn_min": 40, "warn_max": 300, "normal_max_si": 3.4, "normal_min_si": 1, "normal_min_us": 40, "units_si": "mmol/L", "units_us": "mg/dL", "normal_max_us": 130}}, {"default": 0, "label_en": "Tendon xanthomas", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": true, "tips_en": "Patient, 1st degree relative, or 2nd degree relative", "type": "toggle", "name": "xan", "optional": false}, {"label_en": "DNA-based evidence of a functional LDLR, PCSK9 and APOB mutation", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "type": "toggle", "name": "dna", "optional": false}, {"label_en": "Family history of premature CVD events", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "tips_en": "Myocardial infarction <50 years (2nd degree relative) or <60 years (1st degree relative)", "type": "toggle", "name": "cvd", "optional": false}, {"label_en": "Family history of extremely high cholesterol", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "tips_en": ">289.6 mg/dL (7.5 mmol/L) in adult 1st or 2nd degree relative or >258.7 mg/dL (6.7 mmol/L) in a child or sibling <16 years", "type": "toggle", "name": "fam", "optional": false}], "slug": "simon-broome-diagnostic-criteria-familial-hypercholesterolemia-fh", "calc_type": "calculator", "dosing": false, "before_use": "", "md5": "09b3ced3f402846c29847f7fef7cec80", "related_calcs": [{"calcId": 3820, "short_title_en": "US (MEDPED) Diagnostic Criteria for FH", "slug": "us-medped-diagnostic-criteria-familial-hypercholesterolemia-fh"}, {"calcId": 3818, "short_title_en": "Dutch Criteria for FH", "slug": "dutch-criteria-familial-hypercholesterolemia-fh"}, {"calcId": 70, "short_title_en": "LDL Calculated", "slug": "ldl-calculated"}]}